Biomarker testing patterns and patient outcomes for metastatic NSCLC, CRC, and metastatic/recurrent HNSCC at Texas Oncology.

by Beth Weaving | May 20, 2026 | ASCO, Presentations

2026 ASCO Annual Meeting

Management of CML in community setting: Basis for a quality initiative

by Beth Weaving | Oct 7, 2025 | ASCO, Presentations

2025 ASCO Quality Care Symposium

Oncology care model cost data for breast, lung, and multiple myeloma: Influence of outpatient rehabilitation therapy services

by Beth Weaving | Sep 30, 2024 | ASCO, Presentations

JCO Oncol Pract 20, 14(2024)
Volume 20, Number 10_suppl

A Unique Model: Partnership between Community Oncology and Pharma

by Beth Weaving | Jun 1, 2024 | ASCO, Presentations

ASCO Quality 2024, Poster Session

Innovative biomarker testing initiative in a community oncology setting 

by Beth Weaving | Oct 27, 2023 | ASCO, Presentations

ASCO Quality 2023, Poster Session A